Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation.
Saved in:
| Title: | Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation. |
|---|---|
| Authors: | Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.. Electronic address: ryosuke.watari@shionogi.co.jp., Tamura N; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Yoshida S; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Kido Y; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Matsuzaki T; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd. |
| Source: | Journal of pharmaceutical sciences [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2871-2878. Date of Electronic Publication: 2024 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38885812 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Watari+R%22">Watari R</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.. Electronic address: ryosuke.watari@shionogi.co.jp.<br /><searchLink fieldCode="AU" term="%22Tamura+N%22">Tamura N</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.<br /><searchLink fieldCode="AU" term="%22Yoshida+S%22">Yoshida S</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.<br /><searchLink fieldCode="AU" term="%22Kido+Y%22">Kido Y</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.<br /><searchLink fieldCode="AU" term="%22Matsuzaki+T%22">Matsuzaki T</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985195R%22">Journal of pharmaceutical sciences</searchLink> [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2871-2878. <i>Date of Electronic Publication: </i>2024 Jun 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985195R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-6017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223549%22">00223549 </searchLink><i>NLM ISO Abbreviation: </i>J Pharm Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38885812 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.xphs.2024.06.009 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2871 Titles: – TitleFull: Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Watari R – PersonEntity: Name: NameFull: Tamura N – PersonEntity: Name: NameFull: Yoshida S – PersonEntity: Name: NameFull: Kido Y – PersonEntity: Name: NameFull: Matsuzaki T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1520-6017 Numbering: – Type: volume Value: 113 – Type: issue Value: 9 Titles: – TitleFull: Journal of pharmaceutical sciences Type: main |
| ResultId | 1 |
